insights_auto
Zašto je 0QF pao 8,99%?
Istražite detaljnijechevron_right
0QF:FRA
Moderna Inc
163,84 €
arrow_downward
−8,99%(−16,18) 1D
30. ruj, 17:24:15 GMT+2 · EUR
search
Svi simboli
1D
5D
1M
6M
GDD
1G
5G
MAKS
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 0QF...
Otvori
181,30 €
Najviša
181,92 €
Najniža
162,96 €
Trž. kap.
75,30 mlr.
Prosj. kol.
4,02 tis.
Količina
1,68 tis.
52-tjed. najviša
181,92 €
52-tjed. najniža
19,26 €
Broj djelatnika
5 tis.
Otvori
181,30 €
Najviša
181,92 €
Najniža
162,96 €
Trž. kap.
75,30 mlr.
Prosj. kol.
4,02 tis.
Količina
1,68 tis.
52-tjed. najviša
181,92 €
52-tjed. najniža
19,26 €
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
MarketBeat
·
prije 25 minuta
Moderna (NASDAQ:MRNA) Shares Gap Down - Here's Why
NDTV Profit
·
prije 26 minuta
Moderna Shares Plummet 8% As Citi Bear Call Triggers Selloff
Barron's
·
prije 27 minuta
Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter
FinancialContent
·
prije 1 sat
Why Moderna (MRNA) Shares Are Falling Today
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Moderna Inc – informacije
Glavni izvršni direktorStéphane Bancel
Zaposlenici4,7 tis.
Osnovanoruj 2010
Sjedište-
Sektor-
Web-lokacijamodernatx.com